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ABSTRACT
Background: Fever as a common presenting complaint in pediatric patients can be due to various 
causes. Differentiating bacterial infection from other causes is important because the prompt use 
of antibiotics is critical in bacterial infection. Traditional markers of infection such as BT and WBC 
count may be unspecifi c and culture may be late or absent. CRP and Procalcitonin (PCT) have been 
considered to evaluate the evolution of infections and sepsis in patients presenting with SIRS. Neop-
terin has also been proposed to aid in the diagnosis of bacterial infection. In this study, we compared 
the value of the serum PCT, neopterin level, and WBC count for predicting bacterial infection and 
outcome in children with fever. Methods: 158 pediatric (2-120-month-old) patients suspected to 
have acute bacterial infection, based on clinical judgment in which other causes of SIRS were ruled 
out were included in the study. WBC count with differential was determined and PCT and neopterin 
levels were measured. Results: PCT level was higher in bacterial infection and patients who were 
complicated or expired. Conclusion: Rapid PCT test is superior to neopterin and WBC count for 
anticipating bacterial infection, especially in ED where prompt decision making is critical. Abbre-
viations: BT, body temperature; WBC, white blood cell; PCT, procalcitonin; CRP, C-reactive protein; 
SIRS, systemic inﬂ ammatory response syndrome; ED, emergency department.
Keywords: procalcitonin, neopterin, SIRS.
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INTRODUCTION
Fever is a common presenting complaint in 
pediatric emergency department (ED). In most 
children, a benign infection is diagnosed after 
a good history and a careful examination. In 
rare instances, especially in infants, infection is 
manifested only by fever and vague or nonspe-
cifi c signs and symptoms, and no focus is evi-
denced after clinical examination.1,2 Conversely, 
not all patients who appear septic demonstrate 
an infection, and the widespread administra-
tion of antibiotics to all these patients carries 
problems of antibiotic resistance, drug toxicity, 
and increased medical costs.3 Also, differences 
in body temperature (BT), heart rate, white 
blood cell (WBC) count, and respiratory rate 
often are small. As a consequence, diagnosis of 
infection can be diffi cult: positive bacteriologi-
cal samples may be late or absent, the clinical 
interpretation of local colonization may be am-
biguous, and traditional markers of infection 
such as BT and WBC count may be unspecifi c.4 
Other parameters such as C-reactive protein 
(CRP) and procalcitonin (PCT) have been con-
sidered to evaluate the evolution of infections 
and sepsis in patients presenting with systemic 
inﬂ ammatory response syndrome (SIRS).1-3,5
PCT is a 116 amino acid peptide with a se-
quence identical to that of the pro-hormone of 
calcitonin,2 normally synthesized by the C-cells 
of thyroid gland, and its level in blood of healthy 
people is less than 0.01 ng/mL. In bacterial in-
fection and sepsis, however, its level increases 
to 20-200 ng/mL and is related to the severity 
of sepsis.3,6-8 As the level of PCT rises in patients 
who have been underwent to thyroidectomy, it 
seems that in bacterial infections PCT must be 
synthesized somewhere other than the thyroid 
gland, most probably in the liver or monocytes, 
in response to cytokines such as IL-6 and TNF-
α.9,10 PCT increases in blood 6 hours after a 
stimulus, reaches a plateau between 12 and 48 
hours, and then decreases if the stimulus stops. 
CRP increases later than PCT.1
Neopterin has also been proposed to aid in 
the diagnosis of bacterial infection.11 Neopterin is 
a pyrimidine derivative, found to be raised in pa-
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tients suffering from infections, neoplastic and inﬂ ammatory 
diseases.12 Human monocytes/macrophages produce neop-
terin when stimulated by interferon-γ released from activated 
T cells. Other cell types do not produce measurable amounts of 
neopterin following various stimuli. Therefore, neopterin pro-
duction appears to be closely associated with activation of the 
cellular immune system.13 The biological function of neopterin 
is not completely clear: it is associated with nitric oxide synthe-
sis and formation of reactive metabolites of oxygen, and it may 
be toxic to microorganisms. Increased concentrations are relat-
ed to endothelial damage and risk for septic complications.14,15 
The upper limit of the normal range is approximately 
10 nmol/L serum (= 2.5 ng/mL).13 In contrast to PCT, neop-
terin also increases in viral infections.16
In this study, we aimed to compare the value of serum 
PCT, neopterin level, and WBC count for predicting bacte-
rial infection and outcome in children with fever.
 
MATERIAL AND METHODS
During a 12-month period, 200 pediatric (2-120-month-
old) patients admitted to ED and Infectious Disease ward 
of a tertiary university hospital, suspected to have acute bac-
terial infection based on clinical judgment, were included 
in the study. Patients with other causes of SIRS (trauma, 
inﬂ ammation and burn) that could explain their signs and 
symptoms were excluded. Thus, 158 patients were selected 
and demographic data were collected. Blood samples were 
taken from all patients. WBC count with differential was 
determined and PCT and neopterin levels were measured. 
The serum PCT level was measured by a rapid semiquanti-
tative immunochromatographic test (Brahms PCT-Q, Hen-
nigsdorf, Germany). Brieﬂ y, the patient plasma was applied 
onto the test strip. PCT in the sample is bound by mouse 
anti-catacalcin antibodies conjugated with colloidal gold to 
form a complex. This complex moves by means of capillarity 
through an area containing fi xed anti calcitonin antibodies 
to form a sandwich complex that can be seen as a reddish 
band. The color intensity of the band is directly propor-
tional to the PCT concentration of the sample. The results 
were reported as following ranges: < 0.5 ng/mL, ≥ 0.5 and 
< 2 ng/mL, ≥ 2 and < 10 ng/mL, ≥ 10 ng/mL. The serum ne-
opterin level was measured by enzyme-linked immunoassay 
(ELISA).
Bacterial infection was defi ned as positive blood, urine 
or CSF culture or CXR compatible with pneumonia or posi-
tive culture of synovial or peritoneal ﬂ uid. The outcome was 
classifi ed as: 1) cured; 2) complicated or expired.
 
STATISTICAL ANALYSIS
The Kolmogorov–Smirnov test was used to assess sample dis-
tributions. To compare two independent samples, we used an 
unpaired t-test or the Mann–Whitney U-test (data non-nor-
mally distributed). To compare three independent groups, we 
used analysis of variance or the Kruskal–Wallis test (data non-
normally distributed). We used the chi-square test to compare 
proportions; p < 0.05 was considered signifi cant. Statistical 
calculations were performed with SPSS statistical software 
(version 16.0; SPSS Inc., Chicago, IL, USA).
 
RESULTS
200 pediatric patients were included in this study and 42 
were excluded because they were supposed to suffer from 
other causes of SIRS (trauma, inﬂ ammation, burn) except 
infection. Therefore, data of 158 cases were analyzed. Patient 
population included 82 (51.9%) male and 76 (48.1%) fe-
male. Mean age of patients was 42.8 ± 3.5 months. The com-
monest site of infection was urinary tract, followed by lungs. 
In 13 (8.2%) cases no site of infection was found (FUO). 
Mean WBC count and neopterin level in patients with bac-
terial and non-bacterial infection is shown in Table 1.
WBC count was signifi cantly higher in bacterial infec-
tion (p = 0.009). WBC count ≥ 1,2000/mm3 was suggestive of 
bacterial infection with sensitivity of 51.9% and specifi city of 
70%. Serum PCT level increased in bacterial infection (Fig-
ure 1); 35.1% of patients suffering from bacterial infection 
Table 1. Mean WBC count neopterin level in patients 
with bacterial and non bacterial infection
Type of infection  WBC/mm3 neopterin (nmol/L)
Bacterial 10,486.21 44.43
Non-bacterial 7,244.33 42.93
Figure 1: PCT level in bacterial and non-bacterial infection. 
1 = PCT < 0.5, 2 = PCT ≥ 0.5 and < 2, 3 = PCT ≥ 2 and < 10, 
4 = PCT ≥ 10 ng/mL.
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had PCT < 0.5 ng/mL and 29.8% had PCT ≥ 10 ng/mL. 
In non-bacterial infection group, PCT was less than 0.5 
ng/mL in 46.9% and 10 ng/mL or more in 11.2% (p = 
0.014). Considering PCT level ≥ 10 ng/mL as strongly 
positive PCT test, the difference was more significant: 
29.3% with bacterial infection and 11.2% with non-bac-
terial infection had PCT ≥ 10 ng/mL (p = 0.006). Sen-
sitivity and specificity of PCT test with cut-off point of 
10 ng/mL for predicting bacterial infection was 29.3% 
and 88.7%, respectively. Mean neopterin level was 44.43 
nmol/L in bacterial infection and 42.93 nmol/L in non-
bacterial (viral or fungal) infections which was not statis-
tically significant (p = 0.88).
Mean WBC count was signifi cantly lower in cured pa-
tients (5,184.21/mm3) in comparison to uncured group 
(11,412.63/mm3) (p < 0.001). Five out of 49 (10.2%) pa-
tients with PCT level < 0.5 ng/mL was complicated or ex-
pired and 44 (89.8%) cured, while among 24 patients with 
PCT ≥ 10 ng/mL, 9 (37.5%) were complicated or expired 
and 15(62.5%) cured (p = 0.03). 88.2% of patients with 
PCT < 10 ng/mL cured, while the cure rate was 62.5% for 
patients with PCT ≥ 10 ng/mL (p = 0.006). Neopterin level 
was not signifi cantly different in patients who cured and 
those complicated or expired (p = 0.59). Table 2 shows the 
cure rate in different PCT groups. 
101 patients admitted to a medical ICU and suggested 
PCT as a more reliable marker of sepsis than CRP, IL-6 
and lactate levels. Selberg et al.20 study suggested PCT, IL-6 
and C3a concentrations more reliable parameters for dif-
ferentiating between septic and SIRS patients than CRP 
and elastase. Balcl et al.21 compared PCT with CRP, IL-2, 
IL-6, IL-8, and tumor necrosis factor-α as an early sepsis 
marker. These data indicated PCT as a useful early marker 
for discriminating between SIRS and sepsis CRP and PCT 
have different kinetics and profi les. The kinetics of CRP is 
slower than that of PCT, and CRP levels may not further 
increase during more severe stages of sepsis. On the con-
trary, PCT rises in proportion to the severity of sepsis and 
reaches its highest levels in septic shock. PCT tends to be 
higher in non-survivor than in survivor. Therefore, PCT 
demonstrated a closer correlation with the severity of sep-
sis and outcome than CRP.22 Neopterin (D-erythro-1’,2’,3’-
trihydroxypropylpterin) was fi rst isolated from human 
urine in 1965.23 The discovery of neopterin as a marker 
for T-cell activation dates back to the 1980s.24 Neopterin 
is formed preferentially in response to Th1-type cytokine 
interferon-γ, and, because of its ability to amplify delete-
rious effects of radicals in various cellular systems, neop-
terin seems part of the pro-inﬂ ammatory and cytocidal 
armature of the activated human macrophage.25 Neopterin 
concentrations are among the best predictors of the future 
disease course in patients with cardiovascular disorders, 
after multiple traumas and with several types of cancer.26 
In patients with HIV infection, neopterin concentrations 
are even more closely related with survival than virus load. 
Monitoring of neopterin concentrations also allows early 
detection of immunological complications in allograft re-
cipients. Because of its high sensitivity to detect acute virus 
infections early, neopterin screening is nationwide in use 
to improve virus safety in blood donation in Austria.27 PCT 
and neopterin are novel markers introduced for predicting 
infection. Various recently published studies indicated that 
there is a signifi cant relationship of PCT not only to infec-
tion and systemic inﬂ ammation, but also to the outcome 
of the disease. In our study, the serum PCT level was sig-
nifi cantly higher in bacterial infection and in patients with 
more severe infection who were complicated or expired. 
Currently, PCT was related to the severity of the disease. 
Neopterin level had no relationship to bacterial infection. 
As neopterin level rises in viral infections as well as bacte-
rial infections, it was expected not to detect any difference 
in neopterin level of these two groups. PCT is a rapid test 
that can predict bacterial infection and outcome of disease. 
PCT level of 10 ng/mL or more is suggestive of bacterial in-
fection and associated with poor prognosis, while normal 
PCT level (less than 0.5 ng/mL) indicates better prognosis 
and low probability of bacterial infection. Applying this 
test in ED will lead to better decision making for starting 
antibiotics. 
DISCUSSION
The diagnosis of bacterial infection in pediatric patients 
is not always straightforward. Clinical manifestations 
of bacterial and non-bacterial infections are the same 
and reflect the host immune response. Routine labora-
tory tests in patients presenting with SIRS frequently 
lack both sensitivity and specificity in differentiat-
ing which patients should receive antibiotics, and cul-
ture that confirms the diagnosis are not immediately 
available.16,17 Early institution of an appropriate antimi-
crobial regimen in infected patients is associated with 
a better outcome.3,4 On the other hand, inappropriate 
use of antibiotics can cause resistance to these widely 
prescribed, useful drugs. Assicot et al.18 first described 
high serum PCT concentrations in children with severe 
bacterial infections. Suprin et al. compared PCT and 
CRP in ICU patients with positive SIRS and suggested 
CRP as a more specific and sensitive sepsis marker than 
PCT.19 But at the same time, Muller et al.6 investigated 
Table 2. The cure rate in different PCT groups
PCT level (ng/mL) < 0.5 ≥ 0.5 & < 2 ≥ 2 & < 10 ≥ 10
Cure rate 91.2% 80.0% 85.7% 40.0%
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CONCLUSION
Rapid PCT test is superior to neopterin and WBC count 
for anticipating bacterial infection, especially in ED where 
prompt decision making is critical. With regards to test ex-
penses, measurement of neopterin concentration, which 
does not reveal any additional information, to aid diagnosis 
is not worthwhile.
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